Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival-Reference-Cited by-同舟云学术

Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival

Published:2015-11-02 Issue:5 Volume:68 Page:702-712
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Thike Aye A.¹,Tan Puay H.¹,Ikeda Murasaki¹,Iqbal Jabed¹

Affiliation:

1. Department of Pathology; Singapore General Hospital; Academia; Singapore Singapore

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12801/fullpdf

Reference68 articles.

1. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer;Thike;Mod. Pathol.,2010

2. Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers;Thike;Am. J. Surg. Pathol.,2010

3. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications;Sørliea;Proc. Natl Acad. Sci. USA,2001

4. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?;Brenton;J. Clin. Oncol.,2005

5. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma;Nielsen;Clin. Cancer Res.,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer;Communications Biology;2022-06-16

2. Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice;Cancers;2021-07-31

3. ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer;Cancers;2021-01-27

4. Prognostic effects of the expression of inhibitor of DNA‑binding family members on patients with lung adenocarcinoma;Oncology Letters;2020-08-21

5. Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer;Breast Cancer Research;2020-06-11